Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar ...
You spot signs of depression in someone you care about or in yourself and want a clear explanation. Research still shows no ...
Dr.: There are well-established therapies that can help those afflicted with SAD to get through the dark winter months ...
Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...
This study suggests is that clinicians "may be able to offer patients a path to meaningful relief in less than 1 week." ...
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
Researchers found that preventing adolescent body dissatisfaction could reduce the population burden of psychiatric conditions.
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...
Environmental pollution is linked to several mental health disorders in Europe, the European Environment Agency (EEA) warned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results